FDA Says Stolen Inhalers from GlaxoSmithKline Facility Pose Risk

SILVER SPRING, Md., July 16 /PRNewswire-USNewswire/ -- The public should be on the lookout for stolen inhalers after some were found in a number of pharmacies. The Food and Drug Administration (FDA) says the safety and effectiveness of thestolen Advair Diskus inhalers cannot be assured, so consumers should not use them.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)

The inhalersused in the treatment of asthma and chronic obstructive pulmonary diseasewere stolen from a GlaxoSmithKline warehouse in August 2009.

Read more about the stolen inhalers, and how you can identify them at

http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm217879.htm

Sign up for e-mail notices of new FDA Consumer Updates at: https://service.govdelivery.com/service/subscribe.html?code=USFDA_9.

View the FDA Consumer Update RSS feed at: http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/Consumers/rss.xml

FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information (www.fda.gov/consumer)" as the source. FDA values feedback on its consumer health information. Send questions, comments, or story ideas to: consumerinfo@fda.hhs.gov.

Media Contact: Jason Brodsky at 301-796-8234; jason.brodsky@fda.hhs.gov

SOURCE U.S. Food and Drug Administration

Back to news